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SUMMARY 
Epizootic of Highly Pathogenic Avian Influenza subtype H5N1 in Nigeria was successfully contained 
during the first wave that lasted from 2006 to 2008 without the use of vaccine. Re-current and more 
severe outbreak was witnessed in 2015 and there are suspicions that some farmers may have resorted 
to vaccination to prevent infections in their flocks. We investigate evidence of vaccination in farms 
and the status of vaccination as alternate control for HPAI in Nigeria. The study was carried out in a 
cross section of 24 commercial poultry farms in four States in South West and North Central Nigeria. 
Five hundred and one sera collected randomly were screened by agar gel immunodiffusion (AGID) 
assay for antibody to group specific influenza A nucleoprotein. One hundred and eight sera obtained 
from five H5N1 infected poultry farms were also concurrently screened. Reactive sera were further 
analysed by Hemagglutinin Inhibition (HI) test against H5 antigen using 1% suspension of pooled 
washed chicken red blood cells. Only 8 out of 501 sera (1.6%) had evidence of influenza A antibody. 
All of the 8 samples were from one farm with 20 samples collected representing 40% seroconversion 
at farm level. Three out of those sera   were positive for H5 at HI titer of 3log2. All other sera including 
those obtained from HPAI infected farms were negative for influenza antibody. This study confirms 
limited antibody response to avian influenza subtype H5 most likely due to vaccination in one 
commercial flock. Vaccination against avian influenza by farmers desperate to protect their 
investments may lead to unregulated and suboptimal application of vaccines requiring farmers’ and 
stakeholders’ engagement to forestall negative impact.  
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INTRODUCTION                                            
Highly Pathogenic Avian influenza subtype H5N1 
clade 2.2 was first reported in Nigeria in 2006 and 
the epizootic was successfully contained without 
the use of vaccine (Fusaro et al. 2009; Oladokun 
et al. 2012). Another strain of HPAI belonging to 
clade 2.3.2.1c was re-introduced in 2015. The 
infection spread extensively across the country 
within weeks, also affecting neighbouring West 
African countries (Niger, Cameroon, Ghana, 
Ivory Coast and Burkina Faso) from 2015 to 2016 
and was still detected in 2017 and 2018 (Monne et 
al, 2015; Tassoni et al. 2016; FAO, 2018; Laleye 
et al., 2018). The severity and  spread of the 2015 
outbreaks of HPAI H5N1 in Nigeria was 
attributed to gaps in the control programme, 
unlike successes that was recorded when the 
disease was first introduced in 2006 (Oladokun et 
al., 2012; Shittu et al. 2016). Consequently, the 
infections spread to all agro-ecological regions 
accounting for over 500 cases across 20 states 
within a year (Akanbi et al, 2016). 
Nigeria being the most populous country in Africa 
also have abundant livestock resources including 
the poultry sector that contribute directly to the 
socio-economic,  livelihoods, food security and 
health of the population (Robinson et al., 2014). 
Investments in poultry business are in millions of 
dollars in products and services with several 
multi-level and interconnected industries. Poultry 
therefore contributes hugely to the livelihood and 
prosperity of the nation making investment in 
commercial poultry production attractive with 
high economic value (Akpan et al. 2013). 
Operators in the poultry sector in Nigeria are 
therefore wary of threats to their businesses and 
seek measures to mitigate losses. While rural to 
urban migration has rapidly increase human 
population in cities, it is followed by 
intensification of poultry production in urban and 
peri-urban areas. Consequently, biosecurity lapses 
in intensive agriculture are both a threat to animal 
health and production, and have public health 
implications. As farming pressure increases, 
people and their livestock are pushed into ever-
closer proximity and disease prevention even 
becomes more difficult. Other consequences of 
intermingling include interspecies transmission of 
zoonotic pathogens like avian influenza at the 
human-animal interface (Van Kerkhove et al., 
2012). Foregoing conditions require holistic 
control approaches including, biosecurity, 
modified agricultural practices and vaccination 
against pathogens of economic and public health 
importance (Bonfoh et al. 2012; Donatelli et al. 
2016; United Nations, 2018). 
Avian influenza is also suspected to be introduced 
through migratory birds from Asia and Europe 
because Nigeria lies on the path of major flyways 
(East-Africa-Asia flyway, Atlantic-America and 
Black Sea/Mediterranean flyway (Ducatez et al. 
2006: Meseko et al., 2018). The tropical climatic 
region with abundant wetlands, rivers and lakes, 
serves as suitable habitat for the stopover for rest 
and feeding of these migratory birds during 
intercontinental movement where they 
contaminate the environment and may infect 
resident birds with avian influenza (Ducatez et al. 
2006). There is now more evidence in support of 
the role of wild migratory birds in the long 
distance transmission of HPAI from Euro-Asia to 
Africa mainly in autumn (FAO, 2017; Meseko et 




al., 2018). The potential risk of re-introduction of 
HPAI into Nigeria therefore raises concern on the 
preparedness and ability of the veterinary services 
and infrastructures to forestall outbreaks and the 
possibility of the virus becoming endemic in 
domestic poultry following persistent circulation. 
Currently the control programme of the 
Government of Nigeria justifiably excludes 
vaccination of poultry birds, banking on successes 
of previous control programme. These include the 
combinations of modified stamping out by 
depopulation, paying compensation to farmers, 
decontamination of premises with improved 
biosecurity that was able to eliminate HPAI H5N1 
clade 2.2 from Nigeria since 2008 (Oladokun et 
al., 2012, OIE, 2013; Coker et al. 2014; Monne et 
al. 2015). It is equally instructive that some 
countries like Egypt and Indonesia that choose to 
vaccinate birds against HPAI during the same 
period were subsequently not free from the 
disease and had persistent outbreaks with the virus 
becoming enzootic (Kayali, et al. 2016; Tarigan et 
al., 2018). However, the intensity of 2015 
outbreaks and failure of the government to 
promptly pay compensation to affected farmers, 
which culminated in delays in culling and lack of 
incentives for poultry owners to promptly report 
outbreaks may have contributed  in prolonged 
circulation of HPAI H5N1 clade 2.3.2.1c (Akanbi 
et al. 2016). Subsequently, dual introduction and 
co-circulation of two distinct genotypes in Nigeria 
from 2015-2017 resulted in intra clade 
reassortments (Tassoni et al., 2016; Laleye et al., 
2018), and spill over transmission to other 
livestock (Meseko et al., 2018).  These episodes 
raise concerns over the ability to effectively 
control HPAI in Nigeria using stamping out and 
decontamination alone bearing in mind, the poor 
adherence to biosecurity, especially in backyard 
poultry sector and the live bird markets (LBMs). 
Biosecurity lapses are further compounded by 
uncontrolled movement of birds and trade in 
poultry and poultry products across a wide 
expanse of agro-ecological zones of Nigeria.  
Added to the burden of circulation of H5N1 clade 
2.3.2.1c, there has been sporadic detections of 
H5N8 clade 2.3.4.4 in farms and LBMs in 2017 
and 2018 (OIE, 2017; FAO, 2018). The 
uncertainty that depopulation and 
decontamination alone may not stop HPAI 
incursion into Nigeria and West Africa, the huge 
economic investment and the associated concerns 
by farmers may have lured some poultry farmers 
to resort to clandestine vaccination as alternative 
or additional measure to control HPAI in order to 
protect their investment. This study investigated 
evidence of such vaccination practices in 
commercial farms and discusses the status of 
vaccination as alternate control in Nigeria. 
 
MATERIALS AND METHODS 
Sample collection 
A cross sectional sampling of 108 sera was carried 
out in four states infected with HPAI, two each in 
the South West and North Central Nigeria during 
HPAI epidemic in 2015-2016 (Figure 1).  In 
another sampling frame, we obtained a total of 
501 sera from 24 commercial poultry farms 
comprising of commercial layers, broilers and 
grower with each sampled farm population 
ranging from  1000 to 10,000 birds. The  first 
sampling in infected farms served as control for 
the second set of sampling in  farms not known to 
be infected with HPAI and the samples were 
randomly collected  based on convenience 
willingness of the farmers involved.  Apart from 




routine vaccination against Newcastle disease, 
fowlpox, Gumboro and other endemic diseases, 
none of these farms admitted 
 to AI vaccination,. Though the birds  had no 
clinical signs suggestive of AI. Table I 
provides summary of the sample distribution 
according to locations. 
Preparation of Antigen for AGID 
Avian influenza antigen was prepared using 
the protocol described by the Centers for 
Veterinary Biologics and National Veterinary 
Service Laboratories (NVSL), Ames Iowa, 
with modifications. Briefly described, chicken 
embryonated eggs were inoculated avian the 
allantoic route with 0.1 ml of homogenised 
parenchymatous tissues from AI infected 
samples obtained from field outbreaks (Monne 
et al., 2015) and incubated until embryo death was 
observed. Allantoic fluid obtained from dead 
embryo were tested for HA activity with 10% 
pooled chicken RBCs prepared with phosphate 
buffered saline (PBS). Chorioallantoic 
membranes from infected eggs were 
harvested and homogenised according 
to the methods by Woolcock (2008). 
The paste obtained was thrice freezed–
thawed, followed by centrifugation at 
2500rpm for 20 minutes. The pellet was 
discarded and the supernatant was 
treated with 0.1% formalin for virus 
inactivation and standardised with 
H5N2 antigen and reference control 
serum kindly provided by Institute 
Zooprofilattico Sperimentale dele 
Venezie (IZSVe), Padova Italy. All 
procedures were carried out in a 
biosafety cabinet using standard 






FIGURE 1.:  Map of Nigeria showing AIV 
infected but seronegative States and States 
Table I: Distribution of samples and results of HPAI 










Lagos 161 (7 farms) *8 (5%) 3(2%) : GMT (1.41) 
Ogun 120 (6 farms) 0 0 
Plateau 140 (7 farms) 
70 (3 farms)+ 
0 0 
Bauchi 80 (4 farms) 
38 (2 farms)+ 
0 0 
Total 501(24 farms) 









suspected to be involved in AIV vaccination in 








Agar gel immunodiffusion 
Sera were screened by AGID test to detect group 
specific ribonucleoprotein (RNP) antigen to 
influenza A and matrix (M) protein according to 
the protocol described in the OIE manual (2015). 
Tests were organised by placing test serum 
adjacent to a known positive antigen (prepared 
and standardised in-house as described earlier). 
Thereafter the reactants were incubated at 350C in 
a humidified incubator and examined after 24 
hours for precipitin lines formed to the 
homologous antigen of the test antibody.  
Hemagglutinination Inhibition 
Hemagglutination-Inhibition (HI) test was carried 
out on influenza A positive sera from the AGID 
assay using H5 subtype as antigen. The test was 
performed in a 96-well V-bottom microtitre plate 
with 1% suspension of pooled washed chicken red 
blood cells prepared in PBS as indicator. Positive 
HI titers of 4log2 indicated inhibition at a serum 
dilution of 1/16 (24) when expressed as the 
reciprocal (OIE, 2015). In this assay, 0.025 ml of 
PBS was dispensed with a micropipette into each 
well of a V-bottomed microtiter plate followed by 
0.025 ml of serum into the first well of the plate. 
Two fold serial dilutions of the serum were made 
across the plate. Thereafter, 0.025 ml of 4 HAU of 
antigen was added to each well and incubated at 
room temperature for 30 minutes. Subsequently 
0.025 ml of 1% pooled chicken RBCs prepared in 
PBS was added to each well and thoroughly 
mixed. Second incubation of 30 minutes at room 
temperature was observed for the time it took 
control RBCs to settle to a distinct button in the 
microtiter plate. The HI titer (the highest dilution 
of serum that caused complete inhibition of 4 
HAU of antigen) was assessed by tilting the plates 
and only wells in which the RBCs streamed at the 
same rate as the control wells were considered HI 
positive.  
 RESULTS AND DISCUSSION 
This investigation showed evidence of antibody 
response to avian influenza in commercial flock in 
South West Nigeria as eight (1.6%) sera out of 501 
collected from apparently healthy birds had 
evidence of influenza A antibody. Distinct line of 
precipitation was recorded when antigen and 
antiserum in the immune diffusion test combined. 
AGID test on 108 sera obtained from poultry 
farms known to be infected with HPAI H5N1 by 
RT-PCR reported in another study (Shittu et al. 
2016) and tested in the current study were 
negative.  Further analysis of influenza A positive 
sera by HI showed 3 sera (2% by state and 15% 
by farm) were positive for H5 antibody; 2 samples 
at marginal titre of 3 log2 and only one sample had 
HI titre of 4 log2 and the overall GMT of 1.41 was 
calculated using the method by Perozo et al. 
(2008).  The H5 antibody detected in this 
investigation is most likely due to seroconversion 
induced by vaccination which is speculated to 
have been clandestinely applied by some farmers 
in the region. One Avian Influenza vaccine bottle 
was recovered from one farm that declined further 
inquiry (Figure 2). 
There are unconfirmed reports of vaccination in 
southwestern region, the hub of poultry 
production in Nigeria by farmers that are 
desperate to protect their business. This may lead 




to such clandestine, unregulated and inappropriate 
application of non-standardized vaccine and 
vaccination practice with resultant misapplication 
and poor antibody responses. In our study, 
antibodies were detected but the titer was 
marginal at less than 4log2, a conventionally 
consideration for HI positivity but less than 











influenza A vaccine is generally evaluated by 
testing the ability of the vaccine to induce a 
significantly high HI titer of 4-5log2 which also 
correlate with protection against field infection 
(Montomoli et al., 2010). According to Hannoun 
(2004), HI antibody titers are read as the 
reciprocal of the highest serum dilution causing 
complete inhibition of agglutination and the 
results can be presented as the percentage 
conversion which have been defined using 
vaccine or wild strains. The vaccine (s) that was 
probably used in the poultry farm evidently 
seroconverted but did not induce significant HI 
titer though sera were positive by both AGID and 
HI and only one farm out of 24 had evidence of 
seroconversion to influenza antigen. The 40% 
seroconversion recorded in that particular farm 
showed that the vaccine used (proprietary identity 
could not be linked to that shown in figure 1) was 
broadly administered in the farm. In this 
investigation (i) the first category of samples 
collected from known HPAI infected farms were 
all negative and justifiably so as HPAI susceptible 
chickens usually die before developing antibodies 
(OIE, 2014) . (11) In the second category of 
samples collected from apparently healthy birds,  
antibody  was detected and not caused by infection 
as no previous or current outbreak was attributed 
to farms in the location (Akanbi et al 2016). 
Though sampling was not representative of all 
farms in southwest region or Nigeria as a country 
and sampling frame was also not systematic but 
targeted at suspect area, vaccine use may not be as 
widely practised as envisaged which is 
understandably so because vaccination against AI 
is not permitted officially by the government 
authorities. The finding also poses questions on 
the quality and potency of unofficial vaccines due 
to breaks in cold chain, since they are usually 
smuggled into the country in order to evade 
regulatory agencies at ports of entry.  
Sera obtained from known HPAI infected farms 
were negative for AI antibody and not surprisingly 
so because of the patho-biological characteristics 
of HPAI H5N1 virus. In previous studies, 
naturally infected birds with HPAI H5N1 die 
shortly without developing antibody and were 
seronegative (Joannis et al., 2008) because death 
occurred shortly after infection without sufficient 
time (2-3weeks) for humoral antibody 
development (OIE, 2014). Though in an AGID 
and HI experimental set up by Brown et al (2006) 
they were able to detect post-inoculation 
antibodies in surviving waterfowls. The period of 
FIGURE 2. : A bottle 
of Avian influenza 
vaccine recovered 
from a poultry farm 
is South West Nigeria.  
 




seroconversion is usually up to two weeks and 
HPAI H5N1 infection in domestic poultry 
especially chickens and turkey is usually 1 to 3 
days period from infection to clinico-pathological 
findings. The rapid onset of mortality does not 
allow antibody development and detection. Hence 
all the sera from infected farms collected before 
depopulation and analysed in our study were 
negative. This also showed that the antibody 
detected in the second category of samples 
(apparently healthy birds) in the study is not likely 
due to infection but vaccination due to its 
specificity to H5. Though we are not able to 
determine what types of vaccines were used 
(inactivated or live attenuated) in this study but 
there is laboratory evidence that the vaccine 
antigen is H5 specific at least in three samples.  In 
previous studies, analysis of antibody levels 
following vaccination with inactivated virus or 
natural exposure to pathogen showed higher post-
vaccination HI antibody titers associated with 
lower rates of infection on subsequent exposure to 
influenza virus (Hannoun, 2004). Lack of 
protective HI titer as observed in this study 
portends a more dangerous scenario where 
farmers may be under false security while avian 
influenza circulates in poultry flocks  with all the 
attendant risks. 
HPAI control strategies may include vaccination 
of poultry in countries where stamping out alone 
is not sufficient because vaccines also offer 
effective tool to reduce virus shedding and risk of 
transmission as well as lower potential zoonotic 
transmission  (Lee and Suarez, 2005; Ellis et al., 
2006; Capua and Marangon 2006). Nigeria was 
under pressure to adopt vaccination as a control 
strategy in 2006 with reference to some countries 
like Vietnam and China that had used vaccine with 
certain degree of success (To et al., 2007). This 
was the same time when vaccination was adopted 
in Egypt in 2006; unfortunately the impact of 
vaccination on the control of AI vaccination in 
Egypt has been poor despite continuous 
vaccination of poultry birds. Frequent outbreaks 
in poultry have also been source of human 
infections and deaths (Peyre et al., 2009). The 
limitations identified in countries where 
vaccination has failed to control HPAI such as 
Egypt include mass vaccination without outbreak 
investigation and management, failure to maintain 
strict bio-security measures, lack of post 
vaccination monitoring, concurrent disease 
conditions, insufficient trainings in the application 
of vaccination and above all, weak institutions and 
infrastructures (Domenech et al. 2009; Peyre et 
al., 2009). Similarly, failure of vaccination 
programme against avian influenza in Indonesia 
was attributed to a number of reasons including 
the use of an unlicensed virus seed strain and 
induction of low levels of protective antibody 
because of an insufficient quantity of vaccine 
antigen, appearance of drift variant field viruses 
that partially or completely overcame commercial 
vaccine-induced immunity (Swayne et al. 2015). 
In the absence of sustained disease surveillance, 
laboratory and field trials on the efficacy of 
vaccines as well as such post vaccination 
monitoring for the differentiation of infected from 
vaccinated animals (DIVA), unregulated 
vaccination in Nigeria and anywhere should be 
discouraged. This would minimise the likelihood 
of avian influenza epizootics in poultry, human 
exposure and potentials for influenza pandemic, 
because unregulated application of vaccine is a 
recipe for disaster (Capua et al. 2004; James-
Berry 2013). While vaccination has been shown to 
boost immune response in the vaccinated, increase 
resistance to field outbreaks, reduce virus 




shedding and transmission, it can be a powerful 
tool to support eradication programmes if used in 
conjunction with other control methods and 
designed as is fit for peculiar agro-ecology (Capua 
and Marangon 2006). 
In the best interest of avian influenza control in 
Nigeria, while still implementing measures that 
works, poultry farmers’ engagement should be 
initiated without further delay. Government 
should therefore regularly hold stakeholder’s 
consultation, discuss the merits and demerits of 
vaccination programmes and get a consensus on 
vaccination no vaccination through consultation. 
This is imperative in building trust in order to have 
full cooperation to agree on the best approaches. 
Such may include canvassing reasons why 
vaccination option may still be delayed or to 
monitor regulated use of vaccines, field 
application and other considerations including 
exit strategy. It is important to forestall unending 
cycles of vaccine usage as it is currently 
experience with Newcastle disease. Negligence 
on the part of government and inappropriate 
application of vaccines by poultry farmers may 
create more problems for the poultry sector, food 
security and public health. 
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